Wotnews is an Australian news monitoring service. Register FREE to monitor Prana Biotechnology.

Prana Biotechnology
60 search results

3 hours, 10 minutes ago Prana looks at Huntington’s
Melbourne company Prana Biotechnology is investigating the potential of its lead compound, PBT2, in Huntington’s disease. PBT2, a metal-protein-attenuating compound (MPAC), is in Phase IIb ...
Life Scientist - 12:25 p.m. Tuesday 2nd December 2008
Coverage & Analysis View Article Email to Friend
16 hours ago Prana Provides Update on Research and Development Programs at AGM
MELBOURNE, AUSTRALIA--(Marketwire - December 1, 2008) - Prana Biotechnology Limited ( NASDAQ : PRAN) ( ASX : PBT) today provided an update of highlights of current and future activities of ...
marketwire - 11:35 p.m. Monday 1st December 2008
Coverage & Analysis View Article Email to Friend
1 week, 6 days ago Prana's Compound Featured in Annals of Neurology
MELBOURNE, Australia, Nov. 18 /PRNewswire-FirstCall/ -- Prana Biotechnology Limited (NASDAQ: PRAN) (ASX: PBT), a biopharmaceutical company focused on the research and development of treatments ...
PR Newswire - 5:05 a.m. Wednesday 19th November 2008
Coverage & Analysis View Article Email to Friend
Prana's Compound Featured in Annals of Neurology
MELBOURNE, Australia, Nov. 18 /PRNewswire-FirstCall/ -- Prana Biotechnology Limited (NASDAQ: PRAN) (ASX: PBT), a biopharmaceutical company focused on the research and development of treatments ...
PR Newswire - 5:05 a.m. Wednesday 19th November 2008
Coverage & Analysis View Article Email to Friend
1 week, 6 days ago Prana's Compound Featured in Annals of Neurology
Prana Biotechnology Limited ( Nasdaq : PRAN / ASX : PBT ), a biopharmaceutical company focused on the research and development of treatments for neurodegenerative ...
EARTHtimes.org - 11:39 p.m. Tuesday 18th November 2008
Coverage & Analysis View Article Email to Friend
Prana's Compound Featured in Annals of Neurology
Prana Biotechnology Limited ( Nasdaq : PRAN / ASX : PBT ), a biopharmaceutical company focused on the research and development of treatments for neurodegenerative ...
EARTHtimes.org - 11:39 p.m. Tuesday 18th November 2008
Coverage & Analysis View Article Email to Friend
3 weeks ago PRAN: To Present At Rodman & Renshaw Investment Conference @ 09:55 ET [delayed]
Ridgeland, MS, NOV 10, 2008 (EventX/Knobias.com via COMTEX) -- PRAN | Quote | Chart | News | PowerRating -- Company representatives of Prana Biotechnology Limited ADS (NasdaqSC: PRAN | Quote ...
TradingMarkets.com - 11:27 p.m. Monday 10th November 2008
Coverage & Analysis View Article Email to Friend
1 month ago Prana to Present at Rodman & Renshaw 10th Annual Healthcare Conference
MELBOURNE, AUSTRALIA--(Marketwire - October 28, 2008) - Prana Biotechnology Limited ( NASDAQ : PRAN) ( ASX : PBT), a biopharmaceutical company focused on the research and development of treatments ...
marketwire - 1:10 a.m. Wednesday 29th October 2008
Coverage & Analysis View Article Email to Friend
2 months, 3 weeks ago Rodman and Renshaw Upgrades Prana Biotechnology (PRAN) to Market Outperform
Rodman and Renshaw upgrades Prana Biotechnology (Nasdaq: PRAN) from Market Perform to Market Outperform. Price target $8. Rodman analyst says, "Following recent partnering activity in the ...
StreetInsider.com - 9:39 p.m. Tuesday 9th September 2008
Coverage & Analysis View Article Email to Friend
4 months ago The Lancet Neurology Publishes Clinical Results of PBT2 in Alzheimer's Disease Patients
The Lancet Neurology Publishes Clinical Results of PBT2 in Alzheimer's Disease Patients FOXBusiness - AN ) ( ASX : PBT ), a biopharmaceutical company focused on the research and ...
Fox Business - 12:11 a.m. Thursday 31st July 2008
Coverage & Analysis View Article Email to Friend
4 months ago Prana Alzheimer's Drug Safe, Improves Brain Function in Study
Prana Biotechnology Ltd. ' s experimental Alzheimer's disease drug was safe and improved brain function in a study, furthering research into the most advanced approach ...
Bloomberg - 5:53 a.m. Wednesday 30th July 2008
Coverage & Analysis View Article Email to Friend
The Lancet Neurology Publishes Clinical Results of PBT2 in Alzheimer's Disease Patients
Prana Biotechnology Limited ( NASDAQ : PRAN ) ( ASX : PBT ), a biopharmaceutical company focused on the research and development of ...
marketwire - 4:35 a.m. Wednesday 30th July 2008
Coverage & Analysis View Article Email to Friend
4 months, 1 week ago Prana Biotechnology Announces Conference Call Following ICAD Presentations
Prana Biotechnology Limited ( NASDAQ : PRAN ) ( ASX : PBT ), a biopharmaceutical company focused on the research and development of treatments for neurodegenerative disorders, announced today ...
CNN Money - 5:41 a.m. Wednesday 23rd July 2008
Coverage & Analysis View Article Email to Friend
4 months, 2 weeks ago Prana Selected for "Hot Topics" and Alzheimer's Association Press Briefing at ICAD
PRAN | Quote | Chart | News | PowerRating - - Prana Biotechnology Limited ( NASDAQ : PRAN | Quote | Chart | News | PowerRating ...
TradingMarkets.com - 10:49 p.m. Thursday 17th July 2008
Coverage & Analysis View Article Email to Friend
Prana Selected for "Hot Topics" and Alzheimer's Association Press Briefing at ICAD
- 07 / 17 / 08 - - Prana Biotechnology Limited ( NASDAQ : PRAN ) ( ASX : PBT ), a biopharmaceutical company focused on the research and development ...
StreetInsider.com - 10:34 p.m. Thursday 17th July 2008
Coverage & Analysis View Article Email to Friend
1234>

Sydney Hotels from $99
Related Publishers
CNN Money
marketwire
Business Spectator ...
RTTNews
TradingMarkets.com
Life Scientist
PR-USA.net